CVRx CRO Robert John departs; Paul Verrastro named interim head of sales

CVRx, Inc.

Robert John terminated as CRO effective Aug 10, 2026; eligible for severance under employment agreement.
Paul Verrastro named Interim Head of Sales, effective immediately; leads search for permanent successor.
Verrastro has 30+ years med-device sales experience; former CMO at CVRx, previously Guidant, Boston Scientific, Medtronic.
CEO Kevin Hykes cites revised commercial outlook and need to improve commercial execution for the change.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.